As
of June 30, 2026, and 2025, the company had the following potentially dilutive securities outstanding that were excluded from the computation
of diluted net loss per common share, as the inclusion of such shares would be anti-dilutive.
SCHEDULE OF COMPUTATION OF DILUTED NET LOSS PER SHARE
| | |
2026 | | |
2025 | |
| | |
June
30 | |
| | |
2026 | | |
2025 | |
| Stock warrants | |
| 173,848 | | |
| - | |
| Stock options | |
| 690,148 | | |
| - | |
| Unvested restricted stock awards | |
| 50,792 | | |
| - | |
| RPD Convertible Note | |
| - | | |
| - | |
| Total | |
| 914,788 | | |
| - | |
|